Preeclampsia with Severe Features at 33 Weeks: Medications Now, Delivery When
A 33-year-old G3P1 at 33 weeks 2 days presents with a 3-day history of frontal headache and new right-upper-quadrant discomfort. BP is 166/112 mmHg on two readings 15 minutes apart, with 2+ proteinuria on dipstick. Platelets 94,000/µL, AST 128 U/L, ALT 110 U/L, creatinine 0.95 mg/dL (baseline 0.6), haptoglobin 68 mg/dL, LDH 320 U/L, uric acid 7.4 mg/dL. Fetal tracing is category I with a reassuring biophysical profile; estimated fetal weight is at the 40th percentile. She received betamethasone 12 hours ago at an outside hospital. She has no prior hypertension and no other medical problems.
1. State the diagnosis and its supporting criteria, then write the immediate medication orders with doses, targets, and monitoring parameters.
Read the worked answer
Diagnosis: preeclampsia with severe features (with partial HELLP). Severe features present:
- BP ≥160/110 mmHg (166/112)
- Platelets <100,000/µL (94,000)
- AST/ALT elevated to roughly 2–3× upper limit of normal
- Right-upper-quadrant pain and persistent headache
- Creatinine 0.95 - not yet >1.1, but she has doubled her baseline and has hemolysis markers (LDH 320, low haptoglobin)
Immediate orders:
- Magnesium sulfate for seizure prophylaxis: 4–6 g IV over 15–20 min, then 1–2 g/h infusion. Continue 24 h postpartum. Monitor patellar reflexes, respiratory rate (≥12–16/min), and urine output (≥30 mL/h); keep calcium gluconate 1 g IV at the bedside. Reduce or stop the infusion if reflexes are absent, respirations fall, or oliguria develops.
- Antihypertensives for sustained ≥160/110: labetalol 20 mg IV, repeat 40–80 mg every 10 min (max 300 mg); OR hydralazine 5–10 mg IV every 20 min; OR nifedipine 10 mg PO every 20 min. Target 130–150/80–100 mmHg - lower slowly, because abrupt maternal hypotension causes fetal hypoperfusion.
- Avoid: ACE inhibitors/ARBs, diuretics (except for pulmonary edema), atenolol, and nitroprusside (cyanide toxicity risk to the fetus).
- Fetal monitoring continuously; strict input/output; hourly vitals; repeat platelets, LFTs, creatinine every 6–12 h. Place a Foley if oliguric.
2. The obstetric team debates delivering now versus completing the steroid course. Construct the argument on both sides and state the specific findings that would force delivery before 34 weeks.
Read the worked answer
The case for delivering now. She already has severe features with a partial HELLP picture at 33w2d. Severe features at ≥34 weeks mandate delivery, and she is 5 days away from that threshold - the question is whether expectant management buys anything. Risks of waiting include progression to complete HELLP, abruption, eclampsia, pulmonary edema, placental insufficiency, and stillbirth. Platelets at 94,000 with RUQ pain are the findings most likely to deteriorate.
The case for waiting 24–48 h. She has received only one dose of betamethasone - 12 hours in, and the full benefit requires 48 hours. Antenatal steroids meaningfully reduce respiratory distress syndrome, IVH, and neonatal death at this gestational age, and she is in a setting with continuous maternal and fetal monitoring where deterioration can be detected early. Delivery at 33 weeks means a NICU stay measured in weeks.
A defensible synthesis: expectant management in a tertiary center with continuous monitoring, aiming to complete the steroid course, with an agreed threshold for abandoning it. Many clinicians would deliver after the steroid window completes at 34 weeks regardless of stability.
Findings that force delivery before 34 weeks regardless of steroids:
- Nonreassuring fetal status or absent/reversed umbilical artery end-diastolic flow
- Eclampsia, pulmonary edema, or abruptio placentae
- Platelets falling below ~100,000 with a downward trend, or <50,000 (also dictates anesthesia planning)
- Progressive renal insufficiency or rising transaminases with RUQ/epigastric pain
- Uncontrolled BP despite three agents
- Abruption or DIC